Sandoz, the generic arm of Novartis (NVS), recently announced that it is voluntarily recalling one lot of its oral contraceptive drug, Estarylla (norgestimate and ethinyl estradiol), in the US. The ...
Sandoz is conducting a voluntary nationwide recall of one lot of Estarylla (norgestimate and ethinyl estradiol) tablets. This recall is following a customer report of a placebo tablet present in a row ...
FOR IMMEDIATE RELEASE - July 03, 2013 - Princeton, New Jersey, – Sandoz is conducting a voluntary nationwide recall to the retailer level of one lot of its Estarylla® (norgestimate and ethinyl ...
The Food and Drug Administration (FDA) has approved Tri-Lo-Estarylla (ethinyl estradiol, norgestimate; Sandoz) tablets for oral contraception. Tri-Lo-Estarylla is a therapeutic equivalent of Ortho Tri ...
Sandoz, the generic arm of Novartis ( NVS), recently announced that it is voluntarily recalling one lot of its oral contraceptive drug, Estarylla (norgestimate and ethinyl estradiol), in the US. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results